Management Team

James A. Wylie, Jr., Chief Executive Officer and President

Mr. Wylie has been a Director of the Company since January 2003, at which time he also became the Company's President and Chief Executive Officer. Prior to joining the Company, Mr. Wylie acted as a consultant from 1994 through 2002, providing strategic advisory and interim executive management services to institutional investors and operating companies in the medical device, health care, chemical and telecommunications industries. Mr. Wylie has more than 30 years of global executive management experience as a Division President, Group Executive, President and Chief Executive Officer of both private and public corporations. Mr. Wylie holds a BS in Chemistry from Bates College.

David B. Swank, Chief Financial Officer

Mr. Swank has been a Director of the Company since March 2003 and served as Chairman of the Audit Committee from that time until he became the Company's Chief Financial Officer, effective September 1, 2003. Mr. Swank is President and Founder of BrookstoneFive, Inc., a private consulting firm engaged in corporate strategy formulation and capital acquisition. Since 1997, Mr. Swank has principally been the President of BrookstoneFive, Inc., although from 2001 to the beginning of 2003, he also served as Executive Vice President and Chief Financial Officer of Melard Technologies, Inc., a New York-based, privately held high-tech developer of wireless computing devices. From 1994 to 1996, he served as Executive Vice President - Corporate Development and Senior Vice President - Chief Financial Officer at Telxon Corporation, a publicly traded developer of mobile computing devices, and from 1989 to 1992; he was Regional Controller for PepsiCo Foods International (PFI), the international snack food subsidiary of PepsiCo, Inc. Mr. Swank’s other experience includes Chief Financial Officer at AVM Systems, Inc., a high-tech developer of Command and Control Systems, and Audit Manager at Peat, Marwick, Mitchell & Company (currently KPMG), an international "Big Four" accounting firm. Mr. Swank earned a BS in Business Administration in the honors accounting program at The Ohio State University in 1980 and an MBA with a concentration in Finance at Southern Methodist University in 1989.

Christopher Geberth, Vice President, Finance & Corporate Controller

Mr. Geberth joined us in May 2004 as Vice President, Finance and Corporate Controller. Mr. Geberth has prior experience in the fields of finance and accounting in technology and manufacturing industries. Mr. Geberth has held positions of Vice President and Controller with Melard Technologies, Inc., a New York based, privately held high tech developer of wireless computing devices, and Vice President and Controller of Netmarket Group, Inc., a privately held e-commerce company. Prior to joining Diomed, Mr. Geberth served as an Audit Manager focusing on emerging growth companies with PricewaterhouseCoopers LLP, an international “Big Four” accounting firm. Mr. Geberth earned his BA in Accounting from Pace University in 1993 and his CPA in New York State in 1995.

John J. Welch, Vice President, North American Marketing

Mr. Welch joined us in October 2002 as Vice President of North American Marketing. He has over 20 years prior experience in marketing, sales and management in the medical device industry. Prior to joining Diomed, Mr. Welch was Worldwide Vice President of Marketing for the surgical division of Haemonetics Corp., and before that he served Johnson & Johnson, CR Bard and Datex (now part of GE Medical) in various sales and marketing capacities. Mr. Welch was also Director of Marketing and Sales for the New England Region of the American Red Cross Blood Program. Mr. Welch holds a BS in medical technology from Framingham State College.

William D. Allan, Managing Director of Diomed. Ltd.

Mr. Allan is responsible for planning, developing and implementing corporate programs related to the management of International operations including research and development, manufacturing, quality, regulatory, finance, information technology, human resources, global customer support and administration as well as sales and marketing outside of the Americas.
 
Prior to joining Diomed, Mr. Allan spent fifteen years with Smith & Nephew in various responsibilities including sales, marketing, business development and general management.  Most recently, he was Global Vice President – Marketing for Smith & Nephew Wound Management with Global strategic responsibilities for marketing .He has worked in South Africa,Canada and most recently in the UK.
 
Mr. Allan studied Dental Surgery at the University of Edinburgh and practiced as a Dental Surgeon in South Africa and in the UK.   He has an MBA from the University of Cape Town and AMP from Insead Business School in Paris. Mr. Allan holds dual British and South African citizenships.